Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Aquestive Therapeutics

United States — Food and Drug Administration & Aquestive Therapeutics

1 shared events · Importance 3 · Last updated Apr 24, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
0
Business
Aquestive Therapeutics Securities Fraud Lawsuits
Aquestive Therapeutics: Aquestive Therapeutics is the defendant in a class action lawsuit for allegedly making false and misleading statements regarding its New Drug Application for Anaphylm, leading to a significant drop in its stock price.
Apr 01, 2026 · 60 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Aquestive Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.